Key result
Post-cardiac transplant patients average 1.5 respiratory infections over 48 months, with lethal fungal cases.
Why the study?
Lung infections are the most common cause of mortality and morbidity in heart transplant recipients, influenced by immunosuppressive treatment factors.
What is the prevalence and type of lung infections in cardiac transplant recipients receiving immunosuppressive therapy?
Population
37 consecutive cardiac transplant patients, mean age 39 years, 75.7% male
Comparison
Impact of antibacterial and antiviral prophylactic treatment on lung infections
Design
Observational cohort study
Follow-up
48 months
Authors
Loading...
Data on pulmonary infections in heart transplant recipients remain preliminary; leaves open optimal prophylaxis strategies.
Observational (n=37)
No
What is the prevalence and type of lung infections in cardiac transplant recipients receiving immunosuppressive therapy?
Respiratory infections are highly prevalent in cardiac transplant recipients, with fungal and specific infections carrying a high risk of mortality.
Ţilea et al. (2013) conducted an observational in Cardiac transplant recipients (n=37). Cardiac transplantation and immunosuppressive therapy was evaluated on Prevalence of respiratory infections. Over 48 months, 37 cardiac transplant recipients experienced 58 respiratory infections (1.5 episodes per patient), with fungal and specific infections resulting in lethal outcomes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: